News Formal

Three ASX companies jockeying to be the next biotech winners

  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 90%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

Clarity Pharmaceuticals reports it eliminated prostate cancer in a patient; LTR Pharma wants to sell nasal viagra; and Opthea has clinical trial results soon.

To make blockbuster returns in the sharemarket, you’ve got to find the winners of tomorrow, not today.

Clarity Pharmaceuticals is a radiopharmaceuticals medical group which uses radiation to target cancers for diagnostic and treatment purposes. Its product offers radiation against cancer cells by injecting radioisotopes named Cu-64 and Cu-67 into a patient, with its targeted nature meaning it tends to have less chronic side effects than the current standard of care chemotherapy.

Excitement around LTR stock has seen it quadruple in value since its December 2023 IPO and management says its product, named Spontan, works faster as it’s inhaled as a nasal spray, so it gets into the bloodstream quicker. But even if it does get approval, it will face a hard slog selling its product against generic competition that retails for just $13.99 a dose at Chemist Warehouse.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 2. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

ASX 200 LIVE: ASX to drop, megacap tech earnings in focusShares are poised to drop 0.8 per cent at the start of trade; Biden exit leaves markets asking what’s next for ‘Trump trade’; Alphabet and Tesla report this week. Follow here more.
Источник: FinancialReview - 🏆 2. / 90 Прочитайте больше »